Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.34 |
| ▸ | APEX1 | P27695 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL190993 | 1.00 | TRPV1 (0.34) | TRPV1APEX1CYP2C19ALDH1A1ALOX15 | |
| SCHEMBL75189 | 0.96 | CYP2C19 (0.33) | TRPV1APEX1CYP2C19ALDH1A1ALOX15 | |
| SCHEMBL28630202 | 0.95 | TRPV1 (0.33) | TRPV1APEX1CYP2C19L3MBTL1 | |
| SCHEMBL28590851 | 0.95 | TRPV1 (0.33) | TRPV1APEX1CYP2C19L3MBTL1 | |
| SCHEMBL28276179 | 0.95 | MEN1 (0.33) | TRPV1APEX1CYP2C19ALDH1A1ALOX15 | |
| Phosphine SCHEMBL8374080 | 0.95 | TRPV1 (0.33) | TRPV1APEX1CYP2C19ALDH1A1ALOX15 | |
| SCHEMBL9483557 | 0.93 | TRPV1 (0.33) | TRPV1L3MBTL1 | |
| SCHEMBL29214246 | 0.92 | TRPV1 (0.32) | TRPV1 | |
| Phosphoric Acid SCHEMBL5026763 | 0.90 | TRPV1 (0.35) | TRPV1APEX1CYP2C19ALDH1A1ALOX15 | |
| SCHEMBL262807 | 0.89 | TRPV1 (0.32) | TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 355 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114085468-A | Solvent-resistant ABS composite material suitable for blow molding and preparation method thereof | 安徽江淮汽车集团股份有限公司 | 2022-02-25 | — | — | CN | claimed |
| CN-110938239-A | Hindered phenol antioxidant and synthesis method thereof | 梁山新翔新材料有限公司 | 2020-03-31 | — | — | CN | claimed |
| EP-0915130-B1 | Anti-ageing agent for copolymers and terpolymers of styrene | RASCHIG GMBH (DE) | 2000-05-31 | — | — | EP | claimed |
| JP-63248848-A | — | — | None | — | — | JP | disclosed |
| JP-11302446-A | — | — | None | — | — | JP | disclosed |
| US-20260098129-A1 | THERMOPLASTIC RESIN AND MOLDED BODY CONTAINING THERMOPLASTIC RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-04-09 | — | — | US | disclosed |
| US-20260071030-A1 | THERMOPLASTIC RESIN, MOLDED BODY CONTAINING THERMOPLASTIC RESIN, AND OPTICAL LENS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-12 | — | — | US | disclosed |
| US-20260062520-A1 | THERMOPLASTIC RESIN AND MOLDED OBJECT INCLUDING THERMOPLASTIC RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2026-03-05 | — | — | US | disclosed |
| EP-4631995-A1 | THERMOPLASTIC RESIN, MOLDED BODY CONTAINING THERMOPLASTIC RESIN, AND OPTICAL LENS | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-10-15 | — | — | EP | disclosed |
| EP-4631991-A1 | THERMOPLASTIC RESIN AND MOLDED BODY CONTAINING THERMOPLASTIC RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-10-15 | — | — | EP | disclosed |
| EP-4631994-A1 | THERMOPLASTIC RESIN AND MOLDED OBJECT INCLUDING THERMOPLASTIC RESIN | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-10-15 | — | — | EP | disclosed |
| EP-0618315-B1 | Improved melt extrusion process | GEN ELECTRIC (US) | 1998-12-09 | — | — | EP | disclosed |
| EP-0745570-A2 | Ultraviolet radiation-curable coatings for optical fibres and optical fibres coated therewith | Borden, Inc. (US) | 1996-12-04 | — | — | EP | disclosed |
| US-5536529-A | Ultraviolet radiation-curable coatings for optical fibers and optical fibers coated therewith | BORDEN, INC. (US) | 1996-07-16 | — | — | US | disclosed |
| EP-0618315-A1 | Improved melt extrusion process | GENERAL ELECTRIC COMPANY (US) | 1994-10-05 | — | — | EP | disclosed |
| US-5352712-A | Modified polyurethane | BORDEN, INC. (US) | 1994-10-04 | — | — | US | disclosed |
| EP-0565798-A1 | Ultraviolet radiation-curable coatings for optical fibers and optical fibers coated therewith | BORDEN, INC. (US) | 1993-10-20 | — | — | EP | disclosed |
| US-5146531-A | Acrylated polyurethane | BORDEN, INC. (US) | 1992-09-08 | — | — | US | disclosed |
| EP-0372321-A1 | Polyphenylene ether-high impact polystyrene blends | GENERAL ELECTRIC COMPANY (US) | 1990-06-13 | — | — | EP | disclosed |
| JP-S63248848-A | POLYETHYLENE TEREPHTHALATE RESIN COMPOSITION | MITSUBISHI KASEI CORP | 1988-10-17 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062520-A1 | THERMOPLASTIC RESIN AND MOLDED OBJECT INCLUDING THERMOPLASTIC RESIN | RER1, PUF60, SEM1 | TRPV1 1348/4885APEX1 1235/4885CYP2C19 2167/4885 |
| US-20260071030-A1 | THERMOPLASTIC RESIN, MOLDED BODY CONTAINING THERMOPLASTIC RESIN, AND OPTICAL LENS | DERL1, WDR1, RIF1 | TRPV1 2664/4885APEX1 4270/4885CYP2C19 2549/4885 |
| US-20260098129-A1 | THERMOPLASTIC RESIN AND MOLDED BODY CONTAINING THERMOPLASTIC RESIN | RER1, EIF2AK1, RIOK1 | TRPV1 4094/4885APEX1 3017/4885CYP2C19 2468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.